These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29053044)

  • 1. Superior ophthalmic vein thrombosis: A rare complication of Graves' orbitopathy.
    Sorrentino D; Taubenslag KJ; Bodily LM; Duncan K; Stefko T; Yu JY
    Orbit; 2018 Jun; 37(3):175-178. PubMed ID: 29053044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Success Treatment of Severe and Active Graves' Orbitopathy with Tocilizumab After Thyroidectomy and Maximum Dose of Intravenous Methylprednisolone.
    Pramono LA
    Acta Med Indones; 2023 Oct; 55(4):475-477. PubMed ID: 38213047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated thrombosis of the internal jugular vein, superior ophthalmic vein and cavernous sinus as the primary manifestation of occult malignancy: a case report.
    Cameron C; Tong JY; Patel S; Foreman A; Selva D
    Orbit; 2024 Aug; 43(4):505-510. PubMed ID: 36995033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves' orbitopathy: a case report and literature review.
    Verrienti M; Gagliardi I; Valente L; Stefanelli A; Borgatti L; Franco E; Galiè M; Bondanelli M; Zatelli MC; Ambrosio MR
    Endocrine; 2024 Aug; 85(2):576-583. PubMed ID: 38517640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves' orbitopathy.
    Harsløf T; Hikmet R; Ebbehøj E; Langdahl B
    Endocrine; 2023 Dec; 82(3):664-672. PubMed ID: 37676399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exophthalmos and multinodular goitre, an unusual combination.
    Okolie K; Chen D; Ghabrial R; Schmidli R
    Endocrinol Diabetes Metab Case Rep; 2019 May; 2019():. PubMed ID: 31051471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography and magnetic resonance imaging approaches to Graves' ophthalmopathy: a narrative review.
    Luccas R; Riguetto CM; Alves M; Zantut-Wittmann DE; Reis F
    Front Endocrinol (Lausanne); 2023; 14():1277961. PubMed ID: 38260158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Graves' ophthalmopathy by radiotherapy: A literature review.
    Beige A; Boustani J; Bouillet B; Truc G
    Cancer Radiother; 2024 Jun; 28(3):282-289. PubMed ID: 38906800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of a relationship between vitamin D and Graves' orbitopathy.
    Lanzolla G; Di Matteo L; Comi S; Cosentino G; Menconi F; Maglionico MN; Posarelli C; Figus M; Marinò M
    J Endocrinol Invest; 2023 Aug; 46(8):1717-1721. PubMed ID: 36696067
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of carotid cavernous fistula mimicking Graves' orbitopathy.
    Cosentino G; Comi S; Maglionico MN; Marinò M
    J Endocrinol Invest; 2024 Jan; 47(1):255-256. PubMed ID: 37347382
    [No Abstract]   [Full Text] [Related]  

  • 11. Current imaging methods for assessing Graves` orbitopathy activity with particular emphasis on FDG-PET.
    Ochmann A; Winder M; Nalewajka-Kołodziejczak J; Chudek J
    Front Endocrinol (Lausanne); 2023; 14():1138569. PubMed ID: 37600686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior Ophthalmic Vein Thrombosis Associated With Asymptomatic COVID-19 Infection.
    Menke BA; Ryu C; Chundury RV
    Ophthalmic Plast Reconstr Surg; 2024 Mar-Apr 01; 40(2):e41-e42. PubMed ID: 38427840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior Ophthalmic Vein Thrombosis: A Case Report in a Previously Healthy Methicillin-Resistant Staphylococcus aureus-Positive Patient.
    Aldhefeery N; Alrashidi SA; Bouhaimed M
    Am J Case Rep; 2024 Jan; 25():e941886. PubMed ID: 38225808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: News in Graves' orbitopathy: patients management and treatments.
    Lanzolla G; Sabini E
    Front Endocrinol (Lausanne); 2023; 14():1270467. PubMed ID: 37664861
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential diagnosis of thyroid orbitopathy - diseases mimicking the presentation or activity of thyroid orbitopathy.
    Nowak M; Nowak W; Marek B; Kos-Kudła B; Siemińska L; Londzin-Olesik M; Kajdaniuk D
    Endokrynol Pol; 2024; 75(1):1-11. PubMed ID: 38497384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral cavernous sinus and ophthalmic vein thrombosis secondary to
    Calo' L; Scarano E; Brigato F; Di Cintio G; Galli J
    Indian J Otolaryngol Head Neck Surg; 2024 Jun; 76(3):2840-2843. PubMed ID: 38883471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The key data from the 2022 European Thyroid Association congress: Toward personalized treatment of Graves' orbitopathy.
    Abeillon-du Payrat J; Caron P
    Ann Endocrinol (Paris); 2023 Dec; 84(6):756-757. PubMed ID: 37285956
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucocorticoids in the treatment of non-infectious superior ophthalmic vein thrombosis - Three cases and a review of the literature.
    Sigurdsson S; Bohman E; Träisk F; Arnljots U
    Am J Ophthalmol Case Rep; 2024 Jun; 34():102027. PubMed ID: 38516054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, Clinical and Imaging Characteristics of Superior Ophthalmic Vein Periphlebitis in Thyroid Eye Disease.
    Goodyear K; Ghiam S; Strawbridge J; Oh AJ; Singh P; Roelofs KA; Rootman DB
    Ophthalmic Plast Reconstr Surg; 2024 Jul-Aug 01; 40(4):399-402. PubMed ID: 38285960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior ophthalmic vein thrombosis in unique double origin: a case report.
    Boutaj T; Lazaar H; Benkirane R; Sbai L; Tabchi M; Hilali Z; El Hachimi R; Tachfouti S; Amazouzi A; Cherkaoui O
    Pan Afr Med J; 2024; 47():119. PubMed ID: 38828422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.